Travoprost Ophthalmic Solution, USP (Ionic Buffered Solution), 0.004%, Rx only, Manufactured by Apotex Inc., Manufactured by: GSMS Incorporated, Camarillo, CA 93012, a) NDC 51407-731-25 (2.5 mL bottle), b) NDC 51407-731-05 (5 mL bottle).
Published June 14, 2023 · Recall initiated: May 25, 2023
Summary
FDA records drug Class II recall D-0867-2023, published June 14, 2023 and initiated May 25, 2023. Recalling firm: Golden State Medical Supply Inc.; Status: Terminated; Reported quantity: 1,920 bottles; Lot: Lot #s: a) GS049666, GS049807, Exp: 03/31/2024; b) GS049667, GS051447, Exp: 09/30/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: Tamper Evidence Seal is missing on secondary container.
What to do
Voluntary: Firm initiated · Letter
Get an email if TRAVOPROST has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TRAVOPROST
- Manufacturer
- Golden State Medical Supply Inc.
- Distributor
- Nationwide in the USA
- Lot
- Lot #s: a) GS049666, GS049807, Exp: 03/31/2024; b) GS049667, GS051447, Exp: 09/30/2024.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALevsin injection (hyoscyamine sulfate injection, USP), 0.5 mg per ml in water for Injection, 1 ml Ampule (BoxJune 14, 2023
- FDABuprenorphine Sublingual Tablets, 8 mg, 30 count-bottles, Rx only, Manufactured by: Sun Pharma, NDCJune 14, 2023
- FDAASCORBIC ACID PRESERVED INJECTION SOLUTION, 500 mg/mL, 30 mL Sterile Multiple-Dose Vial, RX ONLY, CompoundedJune 14, 2023
- FDAGLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275,June 14, 2023
- FDAIntelli-C, Left side suspended Tabletop, REF: 03400010June 7, 2023
- FDATRAVOPROST OPHTHALMIC SOLUTION, USP 0.004% 2.5ML ; NDC/UPC 60505-0593-4; RX; DROPSJune 2, 2021
Questions about this recall
Was Travoprost Ophthalmic Solution, USP (Ionic Buffered Solution), 0.004%, Rx only, Manufactured by Apotex Inc., Manufactured by: GSMS Incorporated, Camarillo, CA 93012, a) NDC 51407-731-25 (2.5 mL bottle), b) NDC 51407-731-05 (5 mL bottle). recalled?
Yes. FDA published recall D-0867-2023 on June 14, 2023. Reported hazard: Lack of Assurance of Sterility: Tamper Evidence Seal is missing on secondary container.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TRAVOPROST.